Novartis
Novartis’ experimental cardiovascular drug fails a pivotal study
Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. A closely watched cardiovascular drug from Novartis failed in a pivotal study, the company said Friday, a major blow to the firm and to efforts to target a common heart disease risk factor. […]
Novartis drug cuts inflammation. A heart outcomes study is to come
Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. A newly acquired Novartis drug successfully lowered signs of inflammation in a midstage study, as experts wait to hear how the company plans to advance the drug as a potential cardiovascular treatment. In […]
Henrietta Lacks’ estate settles with Novartis over immortal cells
Novartis has settled a lawsuit brought by the estate of Henrietta Lacks, alleging the pharmaceutical giant unfairly profited from her cells, which were taken from her tumor without her knowledge in 1951 and replicated in the laboratory to enable major medical advances, including the polio vaccine. Details of the deal, which was finalized this month […]